OOIR: Observatory of International Research

Papers

(The median citation count of Annual Review of Medicine is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines	488
Clinical Phenotypes of Cystic Fibrosis Carriers	378
COVID-19 Vaccines: Adenoviral Vectors	230
Carbon Monoxide Poisoning: From Microbes to Therapeutics	226
Normal Gut Microbiomes in Diverse Populations: Clinical Implications	184
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic Complication	142
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells	141
Treatments for COVID-19	128
Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts	124
New Biological Therapies for Multiple Myeloma	119
Care Models for Cancer Survivors	114
New Therapeutic Approaches to Large-Vessel Vasculitis	109
Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss	95
Club Cell Secretory Protein in Lung Disease: Emerging Concepts and Potential Therapeutics	92
Health Effects of Wildfire Smoke Exposure	91
Cystic Fibrosis Modulator Therapies	81
Exercise in Octogenarians: How Much Is Too Little?	80
Advances in Therapy for Refractory Epilepsy	78
Precision Approaches to Chronic Obstructive Pulmonary Disease Management	78
Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection	76
Spontaneous Coronary Artery Dissection: New Insights into This Not-So-Rare Condition	73
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT	68
Clinical Perspectives on IgG4-Related Disease and Its Classification	60
Phage Therapy for Antibiotic-Resistant Bacterial Infections	58
MELD 3.0 in Advanced Chronic Liver Disease	58

Sleep Health Disparities	57
COVID-19 and Kidney Disease	57
Myocardial Infarction with Nonobstructive Coronary Arteries	56
Genetics of Dilated Cardiomyopathy	46
Update in Adult Transgender Medicine	45
The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies	45
RASopathies in Cardiac Disease	43
The Hospitalist Movement 25 Years Later	43
	43
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment	42
Update on the Porphyrias	39
SGLT2 Inhibitors: The Sweet Success for Kidneys	38
Update on Hepatorenal Syndrome: From Pathophysiology to Treatment	36
Approach to Therapy for Chronic Pouchitis	35
COVID-19 and Diabetes	34
Effects on Cancer Prevention from the COVID-19 Pandemic	34
Endocrine Disorders and COVID-19	33
Emerging Technologies in Cardiac Pacing	32
Candida auris: Epidemiology and Antifungal Strategy	32
Progress in the Management of Pancreatic Neuroendocrine Tumors	30
A Rational Approach to the Treatment of Acute Pulmonary Embolism	29
Advances and Applications of Polygenic Scores for Coronary Artery Disease	29
A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade	28
Update on HIV Chemoprevention	28
Adverse Impact of Cannabis on Human Health	27
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies	27
	26
Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome	26
COVID-19 Thrombotic Complications and Therapeutic Strategies	26
Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys	26
Interventional Pulmonology: Extending the Breadth of Thoracic Care	25
Clonal Hematopoiesis and Its Impact on Human Health	24
COVID-19: Inflammatory Profile	24
Wearable Devices: Implications for Precision Medicine and the Future of Health Care	24
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics	23
What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?	23
COVID-19 Critical Illness: A Data-Driven Review	22
Maternal Mortality in the United States: Trends and Opportunities for Prevention	21
Medical Therapy Alone, Percutaneous Coronary Intervention, or Coronary Artery Bypass Grafting for Treatment of Coronary Artery Disease	21
Chronic Neuromuscular Respiratory Failure and Home Assisted Ventilation	21
New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer	20
Subclinical Atrial Fibrillation: A Silent Threat with Uncertain Implications	19
Exome/Genome Sequencing in Undiagnosed Syndromes	19
Fatty Liver Disease: Diagnosis and Stratification	18
Long-Term Risks of Living Kidney Donation: State of the Evidence and Strategies to Resolve Knowledge Gaps	17
Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients	15